Skip to content

Role Of Energy drinks in alertness.

Effects of Taurine on systemic Inflammation and cognitive function following acute sleep deprivation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/03/003512
Enrollment
20
Registered
2013-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Taurine: Single dose(0.4% taurine present in Red bull) One group- taurine ,other group- placebo(water)- given once Sleep deprivation- two days Control Intervention1: Water: one group- t

Sponsors

Vir Chandra Singh Garhwali Government Medical Science and research institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Normal healthy volunteers with no physical or laboratory abnormalities.

Exclusion criteria

Exclusion criteria: 1) Significant uncontrolled systemic illness, i.e. diabetes, congestive heart failure, renal or hepatic disease. 2) History of consumption of anti inflammatory drugs for four weeks before starting the trial. 3) History of consumption of CNS affecting drugs for four weeks before starting the trial. 4) History of antioxidants or cognition enhancing substances for four weeks before starting the trial. 5) History of smoking and alcohol consumption for last four weeks. 6) Any intake of caffeinated drinks 48 hours prior to study

Design outcomes

Primary

MeasureTime frame
To investigate the role of taurine in modulating the state of inflammation produced due to acute sleep deprivation (acute stressor) in human participants. Timepoint: 25days

Secondary

MeasureTime frame
To follow the effects of taurine in regulation of acute stress induced inflammation in relation to its impact on cognitive performance. To explore the action of taurine on glucose metabolism in acute stress. To report any unprecedented side effects which surface during the trial due to administration of taurine. Timepoint: three weeks

Countries

India

Contacts

Public ContactPriyanka Singh

Vir Chandra Singh Garhwali Govt Institute of Medical Science and Research, Srikot

priyankadec08@gmail.com9557534654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026